Qualified Health, a healthcare AI startup founded in 2023, has closed a $125 million Series B round led by New Enterprise Associates, bringing total funding to $155 million. The round included new investors Transformation Capital, GreatPoint Ventures, Cathay Innovation, Anthropic, and Menlo Ventures’ Anthology fund, alongside existing backers SignalFire, Frist Cressey Ventures, Flare Capital Partners, Healthier Capital, Town Hall Ventures, and Intermountain Ventures.
The company, led by CEO and co-founder Justin Norden, M.D., builds enterprise AI infrastructure for health systems. Rather than offering a single AI application, Qualified Health operates as an embedded technology partner that integrates AI across clinical workflows, data operations, and administrative processes. The platform includes HIPAA-compliant AI chat, purpose-built AI agents, clinical quality registries, and tools that identify care gaps to trigger timely interventions.
Current deployments span several major health systems including Emory Healthcare, University of Rochester Medicine, Jefferson Health, multiple University of Texas System institutions, and Mercy. The company reports over 500,000 users across its health system clients, representing approximately seven percent of U.S. hospital revenue — up from 400,000 users and five percent of hospital revenue in its previous reporting period.
At the University of Texas Medical Branch, Qualified Health’s platform generated an annualized financial impact exceeding $15 million within six months of deployment. The company uses Claude as a core AI model within its platform, and Anthropic’s participation as an investor signals alignment between the model provider and one of its healthcare-focused deployment partners.
The funding reflects a maturing enterprise healthcare AI market where health systems are moving beyond fragmented pilot projects toward comprehensive AI partnerships. Qualified Health’s valuation is estimated between $500 million and $1 billion, placing it among the more highly valued healthcare AI companies at the Series B stage. NEA co-CEO Mohamad Makhzoumi is joining the company’s board as part of the round.
